Trademark: 79071885
Word
CELLULAR GENOME POSITIONING SYSTEM (CGPS)
Status
Dead
Status Code
404
Status Date
Tuesday, April 23, 2019
Serial Number
79071885
Registration Number
3847971
Registration Date
Tuesday, September 14, 2010
Mark Type
4000
Filing Date
Wednesday, April 22, 2009
Published for Opposition
Tuesday, June 29, 2010
Cancellation Date
Tuesday, April 23, 2019

Trademark Owner History
CELLECTIS - Original Registrant

Classifications
1 Chemical, biochemical, biotechnological and bacteriological products used in industry, science, agriculture, horticulture, namely, chemicals used for industrial purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases; chemical, biochemical, biotechnological and bacteriological products for use in research and testing laboratories, namely, chemicals used for research purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; chemical, biochemical, biotechnological and bacteriological preparations for scientific purposes, namely, chemicals used for scientific purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; diagnostic preparations for scientific purposes; proteins being raw materials; reagents for the preparation or transport of biological molecules for scientific purposes
5 Pharmaceutical, veterinary and sanitary preparations, namely, dietetic beverages, foodstuffs and substances for medical purposes, nutritional additives for medical purposes cultures and preparations of microorganisms for medical, pharmaceutical and veterinary purposes, bacteriological preparations for medical, pharmaceutical and veterinary purposes, medicines for veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, medicines for human purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, biological preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical and biochemical preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical and biochemical preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical-pharmaceutical preparations for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites; diagnostic preparations for medical purposes
9 Scientific apparatus and instruments used in the implementation of biochemical analysis and molecular biology techniques, namely, automated biochemical analyzer, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyzer, devices for protein-nucleic acid interaction analysis; scientific apparatus and instruments for the mapping of all molecules' biological activities; data processing apparatus; multimedia products, namely, blank magnetic, blank optical, blank image and blank sound recording media; software for recording scientific and medical data on an on-line computer database in the field of pharmaceuticals and biotechnology, for simulation and design of biological and chemical products; apparatus and instruments for non-medical diagnosis, namely, computer hardware, microscopes, spectrometers
"CELLULAR GENOME POSITIONING SYSTEM"

Trademark Events
Nov 8, 2019
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Nov 8, 2019
Death Of International Registration
May 2, 2019
Change Of Name/Address Rec'd From Ib
Jan 26, 2018
Total Invalidation Processed By The Ib
Dec 28, 2017
Generic Madrid Transaction Sent To Ib
Dec 28, 2017
Generic Madrid Transaction Created
Dec 21, 2017
Total Invalidation Of Reg Ext Protection Created
Apr 21, 2017
Cancelled Section 71
Mar 27, 2014
New Representative At Ib Received
May 18, 2013
Final Decision Transaction Processed By Ib
Feb 28, 2013
Teas Change Of Correspondence Received
Dec 15, 2010
Final Disposition Notice Sent To Ib
Dec 15, 2010
Final Disposition Processed
Dec 14, 2010
Final Disposition Notice Created, To Be Sent To Ib
Sep 14, 2010
Registered-Principal Register
Jun 29, 2010
Published For Opposition
Jun 9, 2010
Notice Of Publication
May 25, 2010
Law Office Publication Review Completed
May 24, 2010
Examiners Amendment Mailed
May 24, 2010
Approved For Pub - Principal Register
May 24, 2010
Examiner's Amendment Entered
May 24, 2010
Examiners Amendment -Written
May 24, 2010
Previous Allowance Count Withdrawn
May 12, 2010
Assigned To Lie
May 3, 2010
Approved For Pub - Principal Register
Apr 7, 2010
Teas Change Of Correspondence Received
Apr 7, 2010
Teas/Email Correspondence Entered
Apr 7, 2010
Correspondence Received In Law Office
Apr 7, 2010
Teas Response To Office Action Received
Oct 30, 2009
Refusal Processed By Ib
Oct 7, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Oct 7, 2009
Refusal Processed By Mpu
Oct 7, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Oct 6, 2009
Non-Final Action Written
Sep 22, 2009
Application Filing Receipt Mailed
Sep 18, 2009
Assigned To Examiner
Sep 18, 2009
New Application Office Supplied Data Entered In Tram
Sep 17, 2009
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24